No results for ‘’
Mankind Pharma Ltd
₹2280
(1.86%)
Mon, 21 Sept 2026, 06:19 pm
Health Technology
Pharmaceuticals: Major
24.5KMankind Pharma Share Price Live Chart
1 Day
(1.86%)
No Result Found
Summary
Market Cap (in Cr)
98179.49
Net Profit (in Cr)
2011.12
P/B
6.98
Sector P/E
33.76
P/E
50.22
EV/EBITDA
30.20
Debt/Equity (Industry)
0.16
Interest Cover (Industry)
17.01
ROCE (Industry)
16.41
RONW (Industry)
14.52
ROE
14.83
ROCE
16.04
Debt/Equity
0.37
EPS (TTM)
48.69
Dividend Yield
0
Book Value
394.77
Interest Cover
6.08
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 72.66 | 72.66 | 72.67 | 72.68 | 72.70 |
| FII | 10.24 | 11.34 | 12.84 | 13.07 | 12.92 |
| DII | 14.46 | 13.25 | 11.92 | 11.50 | 11.48 |
| Public | 2.64 | 2.75 | 2.57 | 2.75 | 2.90 |
| Government | 0 | 0 | 0 | 0.00 | 0.00 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 2738.83 | 2578.53 | 2498.87 | 2418.23 | 2338.57 | 2257.93 | 2097.63 |
| Fibonacci | 2578.53 | 2517.30 | 2479.47 | 2418.23 | 2357.00 | 2319.17 | 2257.93 |
| Camarilla | 2463.28 | 2448.59 | 2433.89 | 2418.23 | 2404.51 | 2389.81 | 2375.12 |
Pivots Level: Classic
R3
+320.60
2738.83
R2
+160.30
2578.53
R1
+80.63
2498.87
S1
-79.67
2338.57
S2
-160.30
2257.93
S3
-320.60
2097.63
Moving Average
Period
Value
10-EMA
2323.14
20-EMA
2339.33
30-EMA
2359.79
50-EMA
2382.82
100-EMA
2378.01
200-EMA
2355.44
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 19 May 2026 | board-meetings | Accounts, Quarterly Results | |
| 03 Feb 2026 | board-meetings | Quarterly Results | |
| 06 Nov 2025 | board-meetings | Quarterly Results, Half Yearly Results | |
| 31 Jul 2025 | dividend | ₹1.00 Dividend /Share | 08 Aug 2025 |
| 08 Jul 2025 | dividend | Interim Dividend - Rs. - 1 | 08 Aug 2025 |
| 03 Jul 2025 | agm | ||
| 18 Jul 2024 | agm | ||
| 24 Aug 2023 | agm |
Peer Comparison
Mankind Pharma Ltd
Dr Reddys Laboratories Ltd
Sun Pharmaceutical Industries Ltd
Divis Laboratories Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Mankind Pharma Ltd About
Mankind Pharma is principally engaged in the manufacturing and trading of pharmaceuticals and health care products. Pursuant to scheme of amalgamation, the Company has three manufacturing facilities at Paonta Sahib in the state of Himachal Pradesh, one manufacturing facility in state of Sikkim, two manufacturing facilities in state of Rajasthan, one manufacturing facility in state of Andhra Pradesh, three in-house research and development centres in the state of Haryana and one research and development centre in the state of Maharashtra to carry out research in pharmaceutical products.
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
1991
Headquarters
CEO
RAMESH CHAND JUNEJA
Employees
Contact
Website
http://www.mankindpharma.com
investors@mankindpharma.com
Phone
91-11-47476600
Location
208 Okhla Industrial Estate, Phase-III, New Delhi, New Delhi, 110020
Mankind Pharma Ltd Company History
| Year | History |
|---|---|
| 2020 |
|
| 2021 |
|
| 2022 |
|
| 2023 |
|
| 2024 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| GOLDMAN SACHS (SINGAPORE) PTE - ODI | block | Sell | 55000 | 2430 | 14 Oct 2025 |
| GOLDMAN SACHS BANK EUROPE SE - ODI | block | Buy | 55000 | 2430 | 14 Oct 2025 |
| GOLDMAN SACHS (SINGAPORE) PTE - ODI | block | Sell | 42245 | 2440 | 13 Oct 2025 |
| GOLDMAN SACHS BANK EUROPE SE - ODI | block | Buy | 42245 | 2440 | 13 Oct 2025 |
| GOLDMAN SACHS (SINGAPORE) PTE.- ODI | block | Buy | 55000 | 2434.1 | 09 May 2025 |
| COPTHALL MAURITIUS INVESTMENT LIMITED | block | Sell | 55000 | 2434.1 | 09 May 2025 |
| SOCIETE GENERALE | block | Buy | 120078 | 2082 | 10 Jul 2024 |
| AURIGIN MASTER FUND LIMITED | block | Buy | 48032 | 2082 | 10 Jul 2024 |
| CITIGROUP GLOBAL MARKETS MAURITIUS PRIVATE LIMITED (ODI) | block | Buy | 48032 | 2082 | 10 Jul 2024 |
| CITIGROUP GLOBAL MARKETS MAURITIUS PVT LTD | block | Buy | 96063 | 2082 | 10 Jul 2024 |
Frequently Asked Questions
1.What is the stock price of Mankind Pharma Ltd?
As of 21/09/2026 at 11:49 PM, Mankind Pharma Ltd shares are trading at ₹2280.
2.What is the market cap. of Mankind Pharma Ltd?
As of 21/09/2026, the market capitalization of Mankind Pharma Ltd is ₹94,050.37 crore.
3.When was Mankind Pharma Ltd founded?
Mankind Pharma Ltd was founded in 1991.
4.What are the P/E and P/B ratios of Mankind Pharma Ltd?
As of 21/09/2026, Mankind Pharma Ltd has a P/E ratio of 46.14 and a P/B ratio of 6.98.
5.How can I buy shares of Mankind Pharma Ltd?
You can buy shares of Mankind Pharma Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.
6.What is the shareholding pattern of Mankind Pharma Ltd?
As of March,2026, promoters hold 72.66% in Mankind Pharma Ltd, while FIIs, DIIs and public shareholders hold 10.24%, 14.46% and 2.64%, respectively.
7.Does Mankind Pharma Ltd pay dividends?
Yes, Mankind Pharma Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹₹1.00 Dividend /Share per share.
8.What is the dividend yield of Mankind Pharma Ltd?
As of 21 September, 2026, the dividend yield of Mankind Pharma Ltd stands at 0.04%.
9.What are the latest financial results of Mankind Pharma Ltd?
For January,2024, Mankind Pharma Ltd reported revenue of ₹12,207.00 crore and a net profit of ₹1,991.00 crore.
10.What is the Stock symbol of Mankind Pharma Ltd?
MANKIND is the stock symbol of Mankind Pharma Ltd.
11.Who is the CEO of Mankind Pharma Ltd?
The CEO of Mankind Pharma Ltd is RAMESH CHAND JUNEJA.